Ismaiel Abdulrahman, Bucsa Camelia, Farcas Andreea, Leucuta Daniel-Corneliu, Popa Stefan-Lucian, Dumitrascu Dan L
2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Drug Information Research Center, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Front Nutr. 2022 Jan 27;9:749969. doi: 10.3389/fnut.2022.749969. eCollection 2022.
Sarcopenia is a major element of malnutrition in liver cirrhosis (LC) and is present in 30-70% of this population, being associated with a poor overall prognosis due to related complications such as hepatic encephalopathy, ascites, and portal hypertension. This systematic review and meta-analysis aimed to evaluate the effects of branched-chain amino acids (BCAA) supplementation on several parameters used to assess sarcopenia in LC.
A comprehensive systematic electronic search was performed in PubMed, EMBASE, Scopus, Cochrane Library, and ClinicalTrials.gov databases using predefined keywords. We included full articles that satisfied the inclusion and exclusion criteria. Quality assessment of included studies was conducted using Cochrane Collaboration's tool and NHLBI quality assessment tools for interventional and observational studies, respectively. The principal summary outcome was the mean difference (MD) in the evaluated parameters. We performed a pre- and post-intervention analysis and comparison between two intervention groups (BCAA vs. controls) of the evaluated parameters when applicable.
A total of 12 studies involving 1,225 subjects were included in our qualitative synthesis and five in our quantitative synthesis. At baseline vs. post-intervention assessment, subjects receiving BCAA supplementation were found to have a significant improvement in skeletal muscle index (SMI) (-0.347 [95% CI -0.628-0.067; -value 0.015]) and mid-arm muscle circumference (MAMC) (-1.273 [95% CI (-2.251-0.294; -value 0.011]). However, no improvements were reported in handgrip (-0.616 [95% CI -2.818-1.586; -value 0.584]) and triceps subcutaneous fat (1.10 [95% CI -0.814-3.014; -value 0.263]).
Following BCAA supplementation, several parameters used to evaluate sarcopenia in LC patients were found to be improved, including SMI and MAMC. Nevertheless, no improvements were seen in handgrip and triceps subcutaneous fat. Results should be interpreted with caution due to the limited methodological quality of the included studies.
肌肉减少症是肝硬化(LC)患者营养不良的主要因素,在该人群中的发生率为30%-70%,与肝性脑病、腹水和门静脉高压等相关并发症导致的总体预后不良有关。本系统评价和荟萃分析旨在评估补充支链氨基酸(BCAA)对用于评估肝硬化患者肌肉减少症的多个参数的影响。
使用预定义关键词在PubMed、EMBASE、Scopus、Cochrane图书馆和ClinicalTrials.gov数据库中进行全面的系统电子检索。我们纳入了符合纳入和排除标准的全文。分别使用Cochrane协作工具和NHLBI质量评估工具对纳入研究进行干预性研究和观察性研究的质量评估。主要汇总结果是评估参数的平均差异(MD)。在适用时,我们对评估参数进行了干预前和干预后的分析以及两个干预组(BCAA组与对照组)之间的比较。
我们的定性综合分析纳入了12项涉及1225名受试者的研究,定量综合分析纳入了5项研究。在基线与干预后评估中,发现补充BCAA的受试者骨骼肌指数(SMI)显著改善(-0.347 [95%CI -0.628 - 0.067;P值0.015])和上臂中部肌肉周长(MAMC)显著改善(-1.273 [95%CI (-2.251 - 0.294;P值0.011])。然而,握力(-0.616 [95%CI -2.818 - 1.586;P值0.584])和肱三头肌皮下脂肪(1.10 [95%CI -0.814 - 3.014;P值0.263])未见改善。
补充BCAA后,发现用于评估肝硬化患者肌肉减少症的几个参数有所改善,包括SMI和MAMC。然而,握力和肱三头肌皮下脂肪未见改善。由于纳入研究的方法学质量有限,结果应谨慎解释。